UK markets closed

Creo Medical Limited (CREO.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
35.00-0.50 (-1.41%)
At close: 04:40PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 126.52M
Enterprise value 116.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.56
Price/book (mrq)2.12
Enterprise value/revenue 3.78
Enterprise value/EBITDA -2.27

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 3-4.37%
S&P500 52-week change 323.76%
52-week high 350.00
52-week low 329.12
50-day moving average 335.58
200-day moving average 335.65

Share statistics

Avg vol (3-month) 3631.45k
Avg vol (10-day) 3358.13k
Shares outstanding 5361.48M
Implied shares outstanding 6361.48M
Float 8313.32M
% held by insiders 120.86%
% held by institutions 145.23%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -70.46%
Operating margin (ttm)-75.50%

Management effectiveness

Return on assets (ttm)-20.40%
Return on equity (ttm)-39.74%

Income statement

Revenue (ttm)30.8M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)11.60%
Gross profit (ttm)N/A
EBITDA -22M
Net income avi to common (ttm)-21.7M
Diluted EPS (ttm)-0.07
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.5M
Total cash per share (mrq)0.05
Total debt (mrq)8.3M
Total debt/equity (mrq)13.88%
Current ratio (mrq)3.83
Book value per share (mrq)0.17

Cash flow statement

Operating cash flow (ttm)-21.6M
Levered free cash flow (ttm)-16.63M